PFG
GNOM icon

Prosperity Financial Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Prosperity Financial Group’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,355
Closed -$1.91M – 129
2023
Q2 		$1.91M Buy
39,355
+55
+0.1% +$2.75K 1.68% 13
2023
Q1 		$1.94M Buy
+39,300
New +$2.02M 1.96% 11

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
MWAM
Manhattan West Asset Management Los Angeles, California $599M AUM 19.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Prosperity Financial Group's GNOM Position: Q3 2023 in Review

Prosperity Financial Group sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2023, closing a stake of 39,355 shares — an estimated $1.91M sold.

Prosperity Financial Group first reported a position in GNOM in Q1 2023 and held it in 2 quarters. The position peaked at $1.94M in Q1 2023. 64 funds tracked by Wall St. Rank hold GNOM as of Q3 2023.

  • Prosperity Financial Group reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
  • Prosperity Financial Group sold 39,355 Global X Genomics & Biotechnology ETF shares in Q3 2023, an estimated $1.91M.
  • Prosperity Financial Group first reported a position in Global X Genomics & Biotechnology ETF in Q1 2023 and held it in 2 quarters.
  • Prosperity Financial Group's Global X Genomics & Biotechnology ETF position peaked at $1.94M in Q1 2023.
  • 64 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2023.

Based on Prosperity Financial Group's 13F filing for Q3 2023, filed 7 Nov 2023.